Scientists probe cell secrets behind diabetes heart risk

NCT ID NCT07556497

Recruiting now Knowledge-focused Sponsor: Weill Cornell Medical College in Qatar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why people with type 2 diabetes often develop heart problems. Researchers will collect blood and urine from 90 volunteers—some with diabetes and heart disease, some with diabetes only, and some healthy—to study special cells called endothelial progenitor cells. The goal is to understand how these cells become dysfunctional and how inflammation plays a role, which could lead to better treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new ways to prevent or treat heart disease in people with type 2 diabetes.
What could go wrong: This is an observational study, not a treatment trial. It is small (90 participants) and early-stage, so findings may not lead directly to therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIO VASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIO VASCULAR DISEASE DIABETE TYPE 2

Contacts and locations

Locations

Hamad Medical Corporation
RECRUITING

Doha, Qatar

More trials for these conditions

Other studies related to the condition(s) this trial covers.